Control Strategies for Tuberculosis Epidemics: New Models for Old Problems
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Tuberculosis, although preventable and curable, causes more adult deaths than any other infectious disease. A theoretical framework for designing effective control strategies is developed and used to determine treatment levels for eradication, to assess the effects of noneradicating control, and to examine the global goals of the World Health Organization. The theory is extended to assess how suboptimal control programs contribute to the evolution of drug resistance. A new evaluation criterion is defined and used to suggest how control strategies can be improved. In order to control tuberculosis, treatment failure rates must be lower in developing countries than in developed countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
The American Journal of Respiratory and Critical Care Medicine
Klocke, R. A., & Sylvester, J. T. (1994) · American Journal of Respiratory and Critical Care Medicine · Cited by 1,307
The global tuberculosis situation and the new control strategy of the World Health Organization
Kochi, A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90017-m · Cited by 843
Treatment of Multidrug-Resistant Tuberculosis
Wood, A. J. J., & Iseman, M. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291108 · Cited by 706
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Brudney, K., & Dobkin, J. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.745 · Cited by 647
The intrinsic transmission dynamics of tuberculosis epidemics
Blower, S. M., Mclean, A. R., Porco, T. C., Small, P. M., Hopewell, P. C., Sanchez, M. A., & Moss, A. R. (1995) · Nature Medicine · doi:10.1038/nm0895-815 · Cited by 471
Self-citationProphylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
Blower, S., & McLean, A. (1994) · Science · doi:10.1126/science.8073289 · Cited by 219
Self-citationImperfect vaccines and herd immunity to HIV
(1993) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1993.0075 · Cited by 185
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.
Park, M. M., Davis, A. L., Schluger, N. W., Cohen, H., & Rom, W. N. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542137 · Cited by 161
Cited by
van den Driessche, P., & Watmough, J. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00108-6 · Cited by 9,977
Dynamical Models of Tuberculosis and Their Applications
Castillo-Chavez, C., 1. Mathematics, C. A. M. S. C., Song, B., & 2. Department of Mathematical Sciences, M. S. U. (2004) · Mathematical Biosciences and Engineering · doi:10.3934/mbe.2004.1.361 · Cited by 2,079
Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein
Mattoussi, H., Mauro, J. M., Goldman, E. R., Anderson, G. P., Sundar, V. C., Mikulec, F. V., & Bawendi, M. G. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002535y · Cited by 1,681
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Austin, D. J., Kristinsson, K. G., & Anderson, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1152 · Cited by 784
Multiplexed Toxin Analysis Using Four Colors of Quantum Dot Fluororeagents
Goldman, E. R., Clapp, A. R., Anderson, G. P., Uyeda, H. T., Mauro, J. M., Medintz, I. L., & Mattoussi, H. (2004) · Analytical Chemistry · doi:10.1021/ac035083r · Cited by 651
VYNNYCKY, E., & FINE, P. E. M. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007917 · Cited by 555
Antimicrobial Use and Antimicrobial Resistance: A Population Perspective
Lipsitch, M., & Samore, M. H. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0804.010312 · Cited by 497
Avidin: A Natural Bridge for Quantum Dot-Antibody Conjugates
Goldman, E. R., Balighian, E. D., Mattoussi, H., Kuno, M. K., Mauro, J. M., Tran, P. T., & Anderson, G. P. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0125570 · Cited by 518
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
Dye, C., Garnett, G. P., Sleeman, K., & Williams, B. G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03199-7 · Cited by 462
The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
Lipsitch, M., Bergstrom, C. T., & Levin, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1938 · Cited by 424
Goldman, E. R., Anderson, G. P., Tran, P. T., Mattoussi, H., Charles, P. T., & Mauro, J. M. (2002) · Analytical Chemistry · doi:10.1021/ac010662m · Cited by 411
A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco
Blower, S. M., Gershengorn, H. B., & Grant, R. M. (2000) · Science · doi:10.1126/science.287.5453.650 · Cited by 390
Self-citationEpidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Dye, C., Williams, B. G., Espinal, M. A., & Raviglione, M. C. (2002) · Science · doi:10.1126/science.1063814 · Cited by 314
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
Cohen, T., & Murray, M. (2004) · Nature Medicine · doi:10.1038/nm1110 · Cited by 277
Halsey, N. A., Coberly, J. S., Desormeaux, J., Losikoff, P., Atkinson, J., Moulton, L. H., Contave, M., Johnson, M., Davis, H., Geiter, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06532-x · Cited by 270
Uncertainty and Sensitivity Analysis of the Basic Reproductive Rate: Tuberculosis as an Example
Sanchez, M. A., & Blower, S. M. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009076 · Cited by 258
Self-citationFarmer, P., & Kim, J. Y. (1998) · BMJ · doi:10.1136/bmj.317.7159.671 · Cited by 256
Simulating the Effect of Quarantine on the Spread of the 1918–19 Flu in Central Canada
Sattenspiel, L. (2003) · Bulletin of Mathematical Biology · doi:10.1006/bulm.2002.0317 · Cited by 120
van de Belt, H., Neut, D., van Horn, J. R., van der Mei, H. C., Schenk, W., & Busscher, H. J. (1999) · Nature Medicine · doi:10.1038/7330 · Cited by 55
Metadata
- Authors
- Blower, S. M., Small, P. M., & Hopewell, P. C.
- Venue
- Science
- Published
- 1996-07-26
- Volume
- 273
- Issue
- 5274
- Pages
- 497-500
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2067900965
- Cited by
- 350
- References
- 11
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.